about
Directional dominance on stature and cognition in diverse human populationsGene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors.Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.Blood pressure response to potassium supplementation is associated with genetic variation in endothelin 1 and interactions with E selectin in rural Chinese.Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations.Genotype imputation for African Americans using data from HapMap phase II versus 1000 genomes projects.Admixture mapping for hypertension loci with genome-scan markers.A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study.Role of gene expression microarray analysis in finding complex disease genes.Genome-wide distribution of ancestry in Mexican Americans.Characterization of autosomal copy-number variation in African Americans: the HyperGEN Study.Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive familiesCommon genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study.Osteopontin promoter polymorphism is associated with increased carotid intima-media thicknessOn transferability of genome-wide tagSNPs.Risk factors for surgical recurrence after ileocolic resection of Crohn's disease.Genetic effect on blood pressure is modulated by age: the Hypertension Genetic Epidemiology Network Study.Characterization of LD structures and the utility of HapMap in genetic association studies.Interactions of genetic variants with physical activity are associated with blood pressure in Chinese: the GenSalt study.NOD2 status and human ileal gene expression.Comprehensive linkage and linkage heterogeneity analysis of 4344 sibling pairs affected with hypertension from the Family Blood Pressure Program.Multivariate and multilocus variance components method, based on structural relationships to assess quantitative trait linkage via SEGPATH.Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in Blacks and Whites of the HERITAGE Family Study.Population differences in the pattern of familial aggregation for sex hormone-binding globulin and its response to exercise training: the HERITAGE Family Study.Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy.Enhanced detection of genetic association of hypertensive heart disease by analysis of latent phenotypes.Global transmission/disequilibrium tests based on haplotype sharing in multiple candidate genes.Genetic association mapping under founder heterogeneity via weighted haplotype similarity analysis in candidate genes.Genetic variants in the renin–angiotensin–aldosterone system and salt sensitivity of blood pressureCombining extremely concordant sibpairs with extremely discordant sibpairs provides a cost effective way to linkage analysis of quantitative trait lociGenome screening using extremely discordant and extremely concordant sib pairsAn investigation of genome-wide associations of hypertension with microsatellite markers in the family blood pressure program (FBPP)Relation of albuminuria to left ventricular mass (from the HyperGEN Study)ATRAID regulates the action of nitrogen-containing bisphosphonates on bone
P50
Q28646221-E851251D-8473-439C-B5D5-DEDAB8714D0DQ33361962-1BB65B38-47BB-4351-AC6B-5A9620370C6BQ34013806-AEB932F4-B203-4BCE-98AD-89284AD79163Q34056706-F2ADD5BB-F316-40D3-BB78-097EF53B802AQ34247188-CDE81E09-BBF5-4207-A6A6-B4B41525935FQ34285635-DF2E0D28-861C-4056-9607-60A8AB657F6DQ34387252-5E6F6BBF-33A3-4015-81D8-DC0038AA613BQ34558031-69B266A7-36CB-42EA-BBAD-ABBE3B82CD64Q34733167-B0DC5580-AF73-44AC-8181-4ED25068B00AQ35092060-A3333495-D695-46AE-880A-A4ECE5469F07Q35591673-00141348-B04F-4131-AE44-1FE35F3F3BBAQ35893440-5DB89AA3-7167-4A94-B0B0-33F82EEE7105Q36853850-86217AF0-5A09-42FB-962F-2A2CE7CF31B8Q36876644-63E52BED-CF29-4442-9CAC-2F7CB296FEACQ36951833-7409A841-0664-49AE-82B6-1D2E0D48E9BCQ36966878-DD84136F-0A59-40C5-8166-CA7FA6E699DAQ37079524-F8F51136-12D8-4827-A07F-F6A8CF7F4C0FQ37115927-2A9A85C1-D13B-491F-BBA1-45E37FF52188Q37247312-05EEC923-C8DF-4911-A53C-2C601C99346EQ37727940-B96F8A95-9628-44C5-8C9C-F2915D0033D5Q41450287-CC5641E6-0B7C-4788-A60E-7ABCACED8B01Q42693536-AD6E7031-3526-409D-BC05-7F99E0006164Q43725603-2095BB6B-F815-4ED7-BF6E-39EFAAAB93DBQ43827205-ECEFB86F-0C2F-4CAC-8EE1-7BCBE32F0390Q46484757-1534D997-8B0A-4526-AC0A-EAD990513AAFQ46616525-9FDBC30B-B1D7-488D-A2DD-A944549B65D3Q48470195-0FF5EC21-F057-47C4-B98F-6EE1D591B9ADQ51988543-BB70287E-ABD4-4768-8A9B-364E294D83C5Q57315995-0FDD45A7-7C0B-4515-AC58-1A98E1BD5FB2Q71902020-78E71C20-6115-4B1A-9344-FD929EE673C5Q74059275-69E34173-A8FC-4C19-9FB0-24D5B5118ED8Q79988314-9B62AE54-B465-4ABA-A86C-F08A3CB9D185Q80453732-D5ECA27A-9B86-4097-915A-15BE58685CE8Q95336532-A710641D-7880-421D-9020-F5BDFCA04DD5
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8527-8145
@en
name
Charles C Gu
@ast
Charles C Gu
@en
Charles C Gu
@es
Charles C Gu
@nl
type
label
Charles C Gu
@ast
Charles C Gu
@en
Charles C Gu
@es
Charles C Gu
@nl
prefLabel
Charles C Gu
@ast
Charles C Gu
@en
Charles C Gu
@es
Charles C Gu
@nl
P106
P1153
24775504800
P31
P496
0000-0002-8527-8145